HIMS launches multi-cancer screening blood test through GRAIL partnership

Go back to HIMS launches multi-cancer screening blood test through GRAIL partnership
(NYSE: HIMS) Delayed: 27.00 -1.87 (6.48%)
Previous Close $28.87    52 Week High
Open $28.68    52 Week Low
Day High $27.30    P/E N/A 
Day Low $26.60    EPS
Volume 14,528,623